Meglitinides
Meglitinides
Meglitinides (pronunciation: meh-gli-tin-ides) are a class of drugs used to treat Type 2 diabetes.
Etymology
The term "Meglitinides" is derived from the chemical structure of the drugs, which contain a moiety that is structurally similar to glitinide.
Definition
Meglitinides are a type of oral hypoglycemic agent that stimulate the pancreas to produce more insulin. They are used in the management of Type 2 diabetes, particularly in patients who have irregular meal patterns or who have had side effects from other types of diabetes medications.
Related Terms
- Repaglinide: A type of meglitinide that is commonly used in the treatment of Type 2 diabetes.
- Nateglinide: Another type of meglitinide, which is faster acting but has a shorter duration of action than repaglinide.
- Type 2 diabetes: A chronic condition that affects the way the body processes blood sugar (glucose).
- Insulin: A hormone produced in the pancreas that regulates the amount of glucose in the blood.
- Oral hypoglycemic agent: A type of medication used to lower blood sugar levels in patients with Type 2 diabetes.
Usage
Meglitinides are taken orally before meals to help control blood sugar levels. They work by stimulating the pancreas to produce more insulin, which helps to lower blood sugar levels.
Side Effects
Common side effects of meglitinides include hypoglycemia (low blood sugar), weight gain, and joint pain. Less common side effects can include skin rash, upset stomach, and changes in liver function.
See Also
External links
- Medical encyclopedia article on Meglitinides
- Wikipedia's article - Meglitinides
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski